Drug recall · November 27, 2013
Ondansetron Injection recall
Why: Presence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL Single-dose Vial, Rx Only, Sterile, Hospira Inc., Lake Forest IL 60045, USA, NDC 0409-4755-03
- Lots / codes
29-484-DK* and 29-510-DK* Exp 05/01/2015 (lot number may be proceeded with an 01)
- Quantity
- 681,400 vials
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- September 24, 2013 · Voluntary: Firm initiated
- Classified
- November 20, 2013
- Reported
- November 27, 2013
- Ended
- October 6, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ondansetron
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.